Competition & Peer Data API & CSV Delivery

Avenir Wellness Solutions Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Avenir Wellness Solutions Inc (AVRW) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q3 2024
Competitors Tracked
1
Publicly traded peers
Peer Group Market Share
1.40 %
vs 7.31 % a year ago
Revenue Growth Y/Y
-81.29 %
Peers: 4.15 %
Net Margin
-281.77 %
Peers: -84.99 %

Key Findings: Avenir Wellness Solutions Inc vs Its Competitors

  • TTM: Trailing 12-month revenue of 3M vs 54M combined for tracked competitors (5.3% combined share).
  • Trending: Latest-quarter revenue run-rate is decelerating (-74.9% annualized vs trailing 12 months), vs holding steady (+0.1%) for its tracked peer group.
  • Growth: Avenir Wellness Solutions Inc generated -81.3% revenue growth year over year in Q3 2024, vs 4.2% for its tracked competitors combined.
  • Profitability: Its -281.8% net margin compares with -85.0% for the peer group.
  • Peer revenue share: Avenir Wellness Solutions Inc accounted for 1.4% of combined revenue among its tracked peer group, down from 7.3% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

AVRW Sales vs. its Competitors, Q3 2024

Avenir Wellness Solutions Inc reported revenue contraction of 81.29 % year on year in Q3 2024, below its competitors' combined revenue growth of 4.15 %.

With a net margin of -281.77 %, Avenir Wellness Solutions Inc reported lower profitability than its competitors (-84.99 %).

Avenir Wellness Solutions Inc generated 1.40 % of the combined sales of its peer group, down from 7.31 % a year earlier.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/AVRW/competitors
https://api.csimarket.com/api/v1/companies/AVRW/relationships
https://api.csimarket.com/api/v1/companies/AVRW/similar
Programmatic access for models, analytics, and integration workflows.

Avenir Wellness Solutions Inc vs. its Competitors, Q3 2024

Revenue growth, year on year

Avenir Wellness Solutions Inc -81.3 %
Competitors combined +4.2 %

Net margin

Avenir Wellness Solutions Inc -281.8 %
Competitors combined -85.0 %

Revenue run-rate vs trailing 12 months

Avenir Wellness Solutions Inc -74.9 %
Competitors combined +0.1 %

TTM net margin

Avenir Wellness Solutions Inc -90.2 %
Competitors combined -144.6 %

TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.

Competitor Financial Benchmarking - TTM Commercial

TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Avenir Wellness Solutions Inc and its 4 competitor groupings. Available under Commercial License.

Entity TTM Revenue Latest Q ×4 Rev Run-rate vs TTM TTM Net Income TTM Net Margin
Avenir Wellness Solutions Inc $12,345M $12,345M +12.3% · Accelerating $1,234M 12.3%
Competitors combined $12,345M $12,345M +12.3% · Accelerating $1,234M 12.3%
High-Confidence Competitors (2) $12,345M $12,345M +12.3% · Accelerating $1,234M 12.3%
Competitor Financial Benchmarking

TTM revenue, run-rate and net margin benchmarking across Avenir Wellness Solutions Inc's competitor groups requires a Commercial License.

For context: the Major Pharmaceutical Preparations industry grew revenue 7.2% year over year, combined, vs -81.3% for Avenir Wellness Solutions Inc. Avenir Wellness Solutions Inc's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.

Avenir Wellness Solutions Inc's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Avenir Wellness Solutions Inc No - - Yes
Competitors combined (1) 0% 100% 100% 0%
High-Confidence Competitors (5) 60% 80% 40% 0%

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q3 2024

1.4%market share
  • Avenir Wellness Solutions Inc1.4%
  • Competitors combined98.6%

Share of combined quarterly revenue of Avenir Wellness Solutions Inc and its 1 tracked competitors.

See Avenir Wellness Solutions Inc's full market share breakdown »

AVRW Stock Performance relative to its Competitors

AVRW Competitors (weighted) Percent change over the selected range

Avenir Wellness Solutions Inc's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.
0%beat U.S.A. 500
Competitors Combined
(0 of 1)
50%beat U.S.A. 500
High-Confidence
(1 of 2)
Entity TTM Share Price Return
(group: median)
vs U.S.A. 500
Avenir Wellness Solutions Inc - -
Competitors combined (1) 40.4% 63.2%
High-Confidence Competitors (2) 40.4% 63.2%
Similar-Size Competitors (0) 40.4% 63.2%
Similar Growth & Profitability (0) 40.4% 63.2%
Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Avenir Wellness Solutions Inc's competitor groups requires a Commercial License.

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

AVRW Stock Performance relative to High-Confidence Competitors

AVRW High-Confidence Competitors (equal-weighted, 6) Percent change over the selected range

5 Best-Performing Tracked Competitors, Trailing 12 Months

#CompetitorTTM Share Price Returnvs U.S.A. 500
1 Aquestive Therapeutics Inc 282.9% Outperformed
Best-Performing Competitor Returns

TTM share price return and U.S.A. 500 outperformance for Avenir Wellness Solutions Inc's best-performing tracked competitors requires a Commercial License.

Source: CSIMarket API, trailing 12 months.

Avenir Wellness Solutions Inc's Comment on Competition and Industry Peers

The company competes with wellness and nutraceutical firms such as True Botanicals, as well as companies specializing in advanced active ingredient delivery platforms, including Lonza, Aquestive Therapeutics, BioDelivery, and LTS Lohmann. These competitors possess significantly greater financial, technical, and human resources. The company's success relies on developing products that meet unmet wellness needs, offering competitive pricing, expanding its intellectual property portfolio, and creating innovative solutions that outperform competing products.

Publicly Traded Peers of Avenir Wellness Solutions Inc

Revenue and income for trailing 12 months, in millions of $, except employees
Company Market Cap Revenues Income Employees
Avenir Wellness Solutions Inc 0.02 3.06 -2.76 -
Aquestive Therapeutics Inc 593.72 54.09 -78.23 147
SUBTOTAL 593.74 57.14 -80.98 147

Sources: Avenir Wellness Solutions Inc's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Avenir Wellness Solutions Inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.

Avenir Wellness Solutions Inc's Competitors Named by the Company

Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.
Competitor Basis Confidence Active Sources
BioDelivery Named by the company 85% 2022 to 2026 3
Aquestive Therapeutics Named by the company 85% 2022 to 2026 3
True Botanicals Named by the company 85% 2022 to 2026 3
LTS Lohmann Named by the company 85% 2022 to 2026 3
IntelGenx Named by the company 85% 2022 to 2026 3
ARx Pharma Named by the company 85% 2022 to 2026 3
Pfizer, Inc. Named by the company 85% 2022 to 2026 3
Lonza Named by the company 85% 2022 to 2026 3
Zim Corp Named by the company 85% 2022 to 2026 3
Competitor Evidence Detail

Filing basis, confidence, active dates and source counts for Avenir Wellness Solutions Inc's named competitors require a Commercial License.

Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.

Avenir Wellness Solutions Inc's Business Segment Mix vs Peers

Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).
Company Largest Segment 2nd Segment 3rd Segment
Aquestive Therapeutics Inc Reportable 100.00 % - -

Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).

Avenir Wellness Solutions Inc's Productivity vs Peers Comparison

Revenue and income per employee, trailing 12 months, in $; market cap in millions of $
CompanyMarket CapRevenue / EmployeeIncome / Employee
Avenir Wellness Solutions Inc 0 - -
Aquestive Therapeutics Inc 594 367,939 -532,156
PEERS TOTAL 594 367,939 -532,156

Avenir Wellness Solutions Inc's Geographic Revenue Exposure vs Peers

Revenue by country/region as reported in each company's most recent filing. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.
Company Largest Market 2nd Market 3rd Market
Aquestive Therapeutics Inc United States 91.69 % Non-US 8.31 % -

Source: revenue geography as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.

Avenir Wellness Solutions Inc's Position in Industry Market Structure

Market-capitalization share and concentration across all 498 companies in Avenir Wellness Solutions Inc's industry classification, broader than the peer set above. Market cap in millions of $.

Avenir Wellness Solutions Inc ranks #0 of 498 companies by market capitalization in its industry, holding 0.00 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 827, indicating a unconcentrated market structure (U.S. antitrust guidance: below 1,500 unconcentrated, 1,500 to 2,500 moderately concentrated, above 2,500 highly concentrated).

Rank Company Market Cap Industry Share
1 Eli Lilly And Company 1,062,533 19.39 %
2 Johnson and Johnson 664,610 12.13 %
3 Beone Medicines Ltd 545,679 9.96 %
4 Abbvie Inc 467,633 8.54 %
5 Merck and Co Inc 1,234 5.2%
6 Novartis Ag 1,234 5.2%
7 Abbott Laboratories 1,234 5.2%
8 Novo Nordisk A 1,234 5.2%
9 Pfizer Inc 1,234 5.2%
10 Vertex Pharmaceuticals Inc 1,234 5.2%
0 Avenir Wellness Solutions Inc 0 0.00 %
Full Industry Market Structure

Market cap and industry share for the rest of Avenir Wellness Solutions Inc's industry peers requires a Commercial License.

Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-09-25.

Avenir Wellness Solutions Inc's Profitability & Cost Structure

Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Major Pharmaceutical Preparations industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (341 companies).
Metric Company Industry Difference
Gross Margin 46.89 % 64.89 % (avg) -18.0 pp
Operating Margin -89.95 % industry median -7.3 pp
EBITDA Margin -72.58 % -7.21 % (avg) -65.4 pp
Capital Intensity (Capex / Revenue) - 4.92 % (avg) -

Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.

Avenir Wellness Solutions Inc's Valuation vs Competitive Position

Valuation multiples vs the Major Pharmaceutical Preparations industry average (341 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns.
Metric Company Industry Average Difference
P/E - 25.1x -
EV / EBITDA - 17.3x -
P/B -0.2x 4.5x -4.6x
Return on Equity 24.19 % industry aggregate 13.85 %
Return on Invested Capital 14.93 % -2.95 % (avg) 17.88 %

Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.

Avenir Wellness Solutions Inc's Multi-Year Financial Trajectory

Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in SEC filings.
Metric 201820192020202120222023
Revenue Growth 223.69 %6.69 %229.21 %---
Operating Margin -1,294.26 %-2,197.75 %-924.33 %--373.16 %-
Return on Invested Capital 99.49 %-50.07 %-40.78 %--202.22 %-
P/E ------

Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.

Avenir Wellness Solutions Inc's Competitive Forces (Porter's Five Forces)

Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.
Force Assessment Basis
Competitive Rivalry High Industry HHI of 827 (see Industry Market Structure & Concentration above)
Supplier Power Not covered on this page See Avenir Wellness Solutions Inc's dedicated suppliers page for concentration and dependency data
Buyer Power Not covered on this page See Avenir Wellness Solutions Inc's dedicated customers page for concentration and dependency data
Threat of Substitutes - No systematic data source for cross-product substitution exists in this system; not estimated

Note: this is a partial, data-grounded application of the framework, not a complete strategic assessment. Rivalry and barriers-to-entry readings are mechanical translations of the HHI and capital-intensity figures shown elsewhere on this page, not independent judgments.

Avenir Wellness Solutions Inc's Industry Attractiveness & Competitive Strength

A CSIMarket composite, not a standard field: each axis is an equal-weighted average of three factors already shown elsewhere on this page (industry growth, industry profitability and rivalry for attractiveness; relative market share, profitability and growth vs industry for strength). Disclosed as a designed methodology, not a precision measurement.

High Strength
Medium Strength
Low Strength
High Attractiveness
Invest / Grow
Invest / Grow
Selective
Medium Attractiveness
Invest / Grow
Selective
Harvest
Low Attractiveness
Selective
Harvest
Harvest / Divest Avenir Wellness Solutions Inc

Avenir Wellness Solutions Inc falls in the Low attractiveness / Low strength cell: Harvest / Divest.

Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.

Avenir Wellness Solutions Inc's SWOT

Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.

Strengths

  • Return on equity 13.9 points above the industry aggregate.

Weaknesses

  • Operating margin 7.3 points below the industry median.
  • Latest-quarter revenue run-rate is decelerating (-74.9% annualized vs trailing 12 months).
  • Piotroski F-Score of 2 or below, the standard financial-distress signal.

Opportunities

No rule matched.

Threats

No rule matched.

Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.

Avenir Wellness Solutions Inc's Financial Strength vs Peers Comparison

Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months
CompanyQuick RatioWorking CapitalDebt / EquityAsset Turnover
Avenir Wellness Solutions Inc 0.00 0.07 - 1.97
Aquestive Therapeutics Inc 2.79 4.53 - 0.36

Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.

Avenir Wellness Solutions Inc's Revenue and Income Growth vs Peers

Quarterly revenue and net income growth, year over year and quarter over quarter
CompanyPeriodRevenue Y/YRevenue Q/QIncome Y/YIncome Q/Q
Avenir Wellness Solutions Inc Q3 2024-81.3 %-33.1 %--
Aquestive Therapeutics Inc Q2 2026+38.1 %-4.3 %--
PEERS TOTAL+27.0 %-4.9 %--

Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.

Avenir Wellness Solutions Inc's Peers' Costs of Sales and Capital Expenditures

Context for revenue growth: peer costs and capex, year over year and quarter over quarter
CompanyPeriodCosts Y/YCosts Q/QCapex Y/YCapex Q/Q
Avenir Wellness Solutions Inc Q3 2024-87.4 %-39.7 %--
Aquestive Therapeutics Inc Q2 2026-11.9 %+15.8 %+98.1 %+307.7 %

Avenir Wellness Solutions Inc's Returns and Turnover vs Peers

ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover
CompanyROAROIROEReceivables TurnoverInventory Turnover
Avenir Wellness Solutions Inc ---5.363.67
Aquestive Therapeutics Inc ---6.372.42

ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).

Avenir Wellness Solutions Inc's Valuation vs Peers

P/E, price to sales, PEG, price to cash flow and price to book
CompanyP/EPrice / SalesPEGP/CFPrice / Book
Avenir Wellness Solutions Inc -0.01---
Aquestive Therapeutics Inc -10.98-15.64-
PEERS AVERAGE-10.3915.72-

P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.